Key result
Body surface mapping evaluates induced ventricular tachyarrhythmia activation patterns and RVOT involvement in Brugada syndrome.
Why the study?
What is the activation pattern of induced ventricular tachyarrhythmias on body surface mapping in patients with Brugada syndrome?
What is the activation pattern of induced ventricular tachyarrhythmias on body surface mapping in patients with Brugada syndrome?
Body surface mapping is utilized to evaluate the arrhythmogenic substrate in the right ventricular outflow tract during induced ventricular tachyarrhythmias in patients with Brugada syndrome.
Body surface mapping may delineate RVOT activation in Brugada VT; leaves open prospective validation for risk stratification or ablation guidance.
Background:Clinical and experimental studies have shown the existence of an arrhythmogenic substrate in the right ventricular outflow tract (RVOT) in patients with Brugada syndrome (BrS). To evaluate the importance of the RVOT, we evaluated the activation pattern of induced ventricular tachyarrhythmias using body surface mapping (BSM) in patients with BrS.
No takes yet. Share an insight, caveat, or question.
Ueoka et al. (2016) studied this question. Body surface mapping was used to evaluate the activation pattern of induced ventricular tachyarrhythmias and the right ventricular outflow tract's role in Brugada syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: